NCT05783544View on ClinicalTrials.gov

Impact of A. Lumbricoides on Pulmonary Aspergillosis Development

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
COPD Exacerbation AcuteAscaris Lumbricoides InfectionChronic Pulmonary Aspergillosis
Interventions
DIAGNOSTIC_TEST

Interleukin-1B

Level of serum interleukin-1B will be detected

DIAGNOSTIC_TEST

Interleukin-4

Level of serum interleukin-4 will be detected

DIAGNOSTIC_TEST

Interleukin-6

Level of serum interleukin-4 will be detected

DIAGNOSTIC_TEST

tumor necrosis factor - a

Level of serum tumor necrosis factor - a will be detected

DIAGNOSTIC_TEST

interferon- gamma

Level of serum interferon- gamma will be detected

Trial Locations (1)

100133

RECRUITING

Research institute of epidemiology, microbiology and infectious diseases, Tashkent

All Listed Sponsors
lead

Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan

OTHER_GOV